We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
-8.68%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$429M
AUM Growth
-$85.5M
Cap. Flow
-$97.3M
Cap. Flow %
-22.7%
Top 10 Hldgs %
56.93%
Holding
56
New
3
Increased
8
Reduced
7
Closed
8

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$10.1M
2
IBB icon
iShares Biotechnology ETF
IBB
+$5.33M
3
NXST icon
Nexstar Media Group
NXST
+$3.08M
4
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$2.82M
5
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
+$2.13M

Top Sells

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$9.98M
2
ILMN icon
Illumina
ILMN
+$9.07M
3
EEFT icon
Euronet Worldwide
EEFT
+$8.81M
4
BABA icon
Alibaba
BABA
+$5.53M
5
XLRN
Acceleron Pharma
XLRN
+$5.5M

Sector Composition

Rank Sector Weight
1 Healthcare 10.31%
2 Communication Services 9.45%
3 Consumer Discretionary 6.48%
4 Financials 5.87%
5 Energy 5.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
1
CALL
Illumina
ILMN
$29.4B
$32.8M 7.65%
123,360
+61,680
+100% +$17.2M
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$27M 6.29%
104,603
– –
CMBT
3
CMB.TECH NV
CMBT
$4.57B
$21.1M 4.93%
1,873,550
-260,353
-12% -$2.68M
IBB icon
4
iShares Biotechnology ETF
IBB
$9.31B
$21.1M 4.91%
195,440
+46,335
+31% +$5.33M
IOVA icon
5
Iovance Biotherapeutics
IOVA
$2.23B
$19.3M 4.5%
644,728
-376,633
-37% -$9.98M
EEFT icon
6
CALL
Euronet Worldwide
EEFT
$3.02B
$18.9M 4.4%
220,000
+70,000
+47% +$9.27M
ATEX icon
7
Anterix
ATEX
$1.83B
$14.2M 3.32%
311,738
– –
BABA icon
8
Alibaba
BABA
$269B
$11.7M 2.73%
60,051
-26,500
-31% -$5.53M
XLRN
9
DELISTED
Acceleron Pharma
XLRN
$10.8M 2.52%
120,264
-70,713
-37% -$5.5M
NYT icon
10
New York Times
NYT
$11.6B
$10.8M 2.52%
351,187
– –
GS icon
11
Goldman Sachs
GS
$313B
$10.3M 2.4%
66,429
+47,439
+250% +$10.1M
NXST icon
12
Nexstar Media Group
NXST
$5.6B
$9.57M 2.23%
165,735
+29,127
+21% +$3.08M
BRK.B icon
13
Berkshire Hathaway Class B
BRK.B
$1.07T
$8.77M 2.05%
47,946
– –
DOCU
14
CALL
DocuSign
DOCU
$9.63B
$7.39M 1.72%
80,000
-90,000
-53% -$7.24M
MMYT icon
15
MakeMyTrip
MMYT
$4.67B
$6.71M 1.56%
560,981
– –
ARGX icon
16
argenx
ARGX
$57.4B
$6.03M 1.41%
45,781
– –
HD icon
17
Home Depot
HD
$332B
$5.57M 1.3%
29,826
– –
IMMU
18
DELISTED
Immunomedics Inc
IMMU
$5.55M 1.29%
411,500
– –
XLF icon
19
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
$5.11M 1.19%
245,309
+102,485
+72% +$2.82M
BITA
20
DELISTED
Bitauto Holdings Limited
BITA
$4.87M 1.14%
468,970
+26,503
+6% +$370K
IMGN
21
DELISTED
Immunogen Inc
IMGN
$4.69M 1.09%
1,375,900
– –
MHK icon
22
Mohawk Industries
MHK
$6.9B
$3.8M 0.89%
49,842
– –
JPM icon
23
JPMorgan Chase
JPM
$939B
$3.56M 0.83%
39,530
– –
GRIN
24
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
$3.32M 0.77%
1,301,975
– –
GTN icon
25
Gray Television
GTN
$407M
$3.13M 0.73%
291,452
+95,602
+49% +$1.73M
1
2

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q1 2020 Portfolio in Review

As of Q1 2020, QVT Financial held 56 positions worth $429M, down 17% from $514M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

QVT Financial withdrew a net $97.3M in Q1 2020, closing 8 positions and reducing 7 holdings. Its most notable exit was Illumina, an estimated $9.07M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, QVT Financial opened a new position in Prevail Therapeutics Inc. Common Stock worth $1.63M.

  • QVT Financial's largest Q1 2020 buy was Prevail Therapeutics Inc. Common Stock: 133,690 shares worth $1.63M.
  • QVT Financial added most to Goldman Sachs in Q1 2020, an estimated $10.1M increase.
  • QVT Financial's biggest Q1 2020 reduction was Iovance Biotherapeutics, cutting an estimated $9.98M.
  • QVT Financial fully exited Illumina in Q1 2020, selling an estimated $9.07M.
  • QVT Financial's ten largest holdings make up 57% of its $429M portfolio in Q1 2020.
  • QVT Financial opened 3 new positions and closed 8 in Q1 2020.
  • QVT Financial's portfolio value fell 17% quarter-over-quarter to $429M.

Based on QVT Financial's 13F filing for Q1 2020, filed 15 May 2020.